Table 3.
|
Development group (
N
= 390,577) |
Validation group (
N
= 105,030) |
||
---|---|---|---|---|
Variables |
Fulfilled 3/3 criteria |
Did not fulfill criteria |
Fulfilled 3/3 criteria |
Did not fulfill criteria |
( n = 223,023, 57.1%) | ( n = 167,554, 42.9%) | ( n = 60,205, 57.3%) | ( n = 44,825, 42.7%) | |
Death, n |
221,167 |
154,512 |
59,763 |
40,712 |
Survival, n |
1,856 |
13,042 |
442 |
4,113 |
Sensitivity (95% CI) |
0.589 (0.587 to 0.590) |
0.595 (0.592 to 0.598) |
||
Specificity (95% CI) |
0.875 (0.870 to 0.881) |
0.903 (0.894 to 0.911) |
||
PPV (95% CI) |
0.992 (0.991 to 0.992) |
0.993 (0.992 to 0.993) |
||
NPV (95% CI) |
0.078 (0.077 to 0.079) |
0.092 (0.089 to 0.095) |
||
Area under the ROC curve (95% CI) | 0.851 (0.850 to 0.852) | 0.874 (0.872 to 0.876) |
aCI, confidence interval; PPV, positive predictive value; NPV, negative predictive value; ROC, receiver operating characteristic.